{ "@graph": [    { "@id": "http://linked.opendata.cz/resource/ATC/L",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Cytostatika a imunomodula\u010Dn\u00ED l\u00E9\u010Diva" , "@language" : "cs" } ,        { "@value" : "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/L01",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "ANTINEOPLASTIC AGENTS" , "@language" : "en" } ,        { "@value" : "Cytostatika" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L01" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/L01B",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Antimetabolity" , "@language" : "cs" } ,        { "@value" : "ANTIMETABOLITES" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L01B" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/L01BA",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Analogy kyseliny listov\u00E9" , "@language" : "cs" } ,        { "@value" : "Folic acid analogues" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L01BA" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/L01BA01",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://www.w3.org/2004/02/skos/core#broaderTransitive" : [ "http://linked.opendata.cz/resource/ATC/L" ,        "http://linked.opendata.cz/resource/ATC/L01" ,        "http://linked.opendata.cz/resource/ATC/L01B" ,        "http://linked.opendata.cz/resource/ATC/L01BA" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Methotrex\u00E1t" , "@language" : "cs" } ,        { "@value" : "Methotrexate" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L01BA01" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Drug hypersensitivity" , "@language" : "en" } ,        { "@value" : "L\u00E9kov\u00E1 alergie" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000010195",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "T\u011Bhotenstv\u00ED" , "@language" : "cs" } ,        { "@value" : "Pregnancy" , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000003529",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Selh\u00E1n\u00ED ledvin" , "@language" : "cs" } ,        { "@value" : "Kidney failure" , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000000575",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Koagulopatie" , "@language" : "cs" } ,        { "@value" : "Blood coagulation disorders" , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000002182",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Neutropenie" , "@language" : "cs" } ,        { "@value" : "Neutropenia" , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000002932",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Thrombocytopenia" , "@language" : "en" } ,        { "@value" : "Trombocytopenie" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000003302",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Hiv infekce" , "@language" : "cs" } ,        { "@value" : "Hiv infections" , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000001867",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Liver diseases, alcoholic" , "@language" : "en" } ,        { "@value" : "Alkoholick\u00E9 nemoci jater" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0013595",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/Ingredient" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Methotrex\u00E1t" , "@language" : "cs" } ,        { "@value" : "Methotrexate" , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPharmacologicalAction" : [ "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0008662" ,        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0007520" ,        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0011171" ,        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0028850" ,        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0000022" ,        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001471" ,        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0027742" ,        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0006057" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA.     " , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPregnancyCategory" : [ "http://linked.opendata.cz/resource/fda-spl/pregnancy-category/X" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/contraindicatedWith" : [ "http://linked.opendata.cz/resource/ndfrt/disease/N0000002182" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000001867" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000003302" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000003529" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000010195" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000000575" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000002932" ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product/METHOTREXATE-HOSPIRA-2-5-MG-TABLETY",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProduct" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasActiveIngredient" : [ "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0013595" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "METHOTREXATE HOSPIRA 2,5 MG TABLETY" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L01BA01" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPregnancyCategory" : [ "http://linked.opendata.cz/resource/fda-spl/pregnancy-category/X" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMedicinalProductPackaging" : [ "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0163332" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0163333" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0163331" ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0000022",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Abortifacient agents, nonsteroidal" , "@language" : "en" } ,        { "@value" : "Abortiva nesteroidn\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Non-steroidal chemical compounds with abortifacient activity.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001471",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Antimetabolites, antineoplastic" , "@language" : "en" } ,        { "@value" : "Antimetabolity antitumor\u00F3zn\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Antimetabolites that are useful in cancer chemotherapy.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0006057",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Dermatologic agents" , "@language" : "en" } ,        { "@value" : "Dermatologick\u00E9 l\u00E1tky" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Drugs used to treat or prevent skin disorders or for the routine care of skin.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0007520",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Enzyme inhibitors" , "@language" : "en" } ,        { "@value" : "Enzymy - inhibitory" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0008662",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Folic acid antagonists" , "@language" : "en" } ,        { "@value" : "Kyselina listov\u00E1 - antagonist\u00E9" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Inhibitors of the enzyme, dihydrofolate reductase (TETRAHYDROFOLATE DEHYDROGENASE), which converts dihydrofolate (FH2) to tetrahydrofolate (FH4). They are frequently used in cancer chemotherapy. (From AMA, Drug Evaluations Annual, 1994, p2033)     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0011171",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Imunosupresiva" , "@language" : "cs" } ,        { "@value" : "Immunosuppressive agents" , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0027742",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Antirheumatic agents" , "@language" : "en" } ,        { "@value" : "Antirevmatika" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Drugs that are used to treat RHEUMATOID ARTHRITIS.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0028850",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Inhibitory synt\u00E9zy nukleov\u00FDch kyselin" , "@language" : "cs" } ,        { "@value" : "Nucleic acid synthesis inhibitors" , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Compounds that inhibit cell production of DNA or RNA.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0163332",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "METHOTREXATE HOSPIRA 2,5 MG TABLETY" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L01BA01" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC115070_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "30" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "P\u0159\u00EDpravek Methotrexate Hospira je indikov\u00E1n k l\u00E9\u010Db\u011B gesta\u010Dn\u00EDho choriokarcinomu, destruuj\u00EDc\u00EDho chorioadenomu a mola hydatidosa. \nD\u00E1le je p\u0159\u00EDpravek Methotrexate Hospira u\u017E\u00EDv\u00E1n jako\u00A0monoterapie anebo v\u00A0kombinaci s\u00A0dal\u0161\u00EDmi cytostatiky k\u00A0l\u00E9\u010Db\u011B akutn\u00ED lymfoblastick\u00E9 leuk\u00E9mie (udr\u017Eovac\u00ED terapie leuk\u00E9mie), pokro\u010Dil\u00FDch stadi\u00ED non-hodgkinsk\u00FDch lymfom\u016F, Burkittova lymfomu, epidermoidn\u00EDch karcinom\u016F hlavy a krku a pokro\u010Dil\u00FDch st\u00E1di\u00ED mycosis fungoides. \nP\u0159\u00EDpravek Methotrexate Hospira je indikov\u00E1n tak\u00E9 pro symptomatickou l\u00E9\u010Dbu psori\u00E1zy u dosp\u011Bl\u00FDch, ale vzhledem k\u00A0z\u00E1va\u017En\u00E9mu riziku l\u00E9\u010Dby pouze v\u00A0p\u0159\u00EDpadech t\u011B\u017Ek\u00E9, \u0161patn\u011B zvl\u00E1dnuteln\u00E9 psori\u00E1zy, kter\u00E1 neodpov\u00EDd\u00E1 dostate\u010Dn\u011B na jin\u00E9 typy l\u00E9\u010Dby. Diagn\u00F3za mus\u00ED b\u00FDt potvrzena biopsi\u00ED a dermatologick\u00FDm vy\u0161et\u0159en\u00EDm. Z\u00E1rove\u0148 je d\u016Fle\u017Eit\u00E9 vylou\u010Dit koincidenci psori\u00E1zy s\u00A0jin\u00FDm onemocn\u011Bn\u00EDm ovliv\u0148uj\u00EDc\u00EDm imunitn\u00ED odpov\u011B\u010F.\nD\u00E1le se p\u0159\u00EDpravek Methotrexate Hospira se pou\u017E\u00EDv\u00E1 v\u00A0terapii z\u00E1va\u017En\u00E9 aktivn\u00ED revmatoidn\u00ED artritidy, kter\u00E1 neodpov\u00EDd\u00E1 na l\u00E9\u010Dbu antirevmatiky prvn\u00ED volby, pod\u00E1van\u00FDmi samostatn\u011B nebo v\u00A0kombinaci s\u00A0inhibitory prostaglandinsyntet\u00E1zy. \n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL NOB 30X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0163333",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "METHOTREXATE HOSPIRA 2,5 MG TABLETY" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L01BA01" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC115070_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "100" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "P\u0159\u00EDpravek Methotrexate Hospira je indikov\u00E1n k l\u00E9\u010Db\u011B gesta\u010Dn\u00EDho choriokarcinomu, destruuj\u00EDc\u00EDho chorioadenomu a mola hydatidosa. \nD\u00E1le je p\u0159\u00EDpravek Methotrexate Hospira u\u017E\u00EDv\u00E1n jako\u00A0monoterapie anebo v\u00A0kombinaci s\u00A0dal\u0161\u00EDmi cytostatiky k\u00A0l\u00E9\u010Db\u011B akutn\u00ED lymfoblastick\u00E9 leuk\u00E9mie (udr\u017Eovac\u00ED terapie leuk\u00E9mie), pokro\u010Dil\u00FDch stadi\u00ED non-hodgkinsk\u00FDch lymfom\u016F, Burkittova lymfomu, epidermoidn\u00EDch karcinom\u016F hlavy a krku a pokro\u010Dil\u00FDch st\u00E1di\u00ED mycosis fungoides. \nP\u0159\u00EDpravek Methotrexate Hospira je indikov\u00E1n tak\u00E9 pro symptomatickou l\u00E9\u010Dbu psori\u00E1zy u dosp\u011Bl\u00FDch, ale vzhledem k\u00A0z\u00E1va\u017En\u00E9mu riziku l\u00E9\u010Dby pouze v\u00A0p\u0159\u00EDpadech t\u011B\u017Ek\u00E9, \u0161patn\u011B zvl\u00E1dnuteln\u00E9 psori\u00E1zy, kter\u00E1 neodpov\u00EDd\u00E1 dostate\u010Dn\u011B na jin\u00E9 typy l\u00E9\u010Dby. Diagn\u00F3za mus\u00ED b\u00FDt potvrzena biopsi\u00ED a dermatologick\u00FDm vy\u0161et\u0159en\u00EDm. Z\u00E1rove\u0148 je d\u016Fle\u017Eit\u00E9 vylou\u010Dit koincidenci psori\u00E1zy s\u00A0jin\u00FDm onemocn\u011Bn\u00EDm ovliv\u0148uj\u00EDc\u00EDm imunitn\u00ED odpov\u011B\u010F.\nD\u00E1le se p\u0159\u00EDpravek Methotrexate Hospira se pou\u017E\u00EDv\u00E1 v\u00A0terapii z\u00E1va\u017En\u00E9 aktivn\u00ED revmatoidn\u00ED artritidy, kter\u00E1 neodpov\u00EDd\u00E1 na l\u00E9\u010Dbu antirevmatiky prvn\u00ED volby, pod\u00E1van\u00FDmi samostatn\u011B nebo v\u00A0kombinaci s\u00A0inhibitory prostaglandinsyntet\u00E1zy. \n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasResumedMarketingDate" : [ { "@value" : "2011-01-01" , "@type" : "http://www.w3.org/2001/XMLSchema#date" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 281.5799865722656 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 597.760009765625 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL NOB 100X2.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0163331",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "METHOTREXATE HOSPIRA 2,5 MG TABLETY" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L01BA01" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC115070_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "30" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "P\u0159\u00EDpravek Methotrexate Hospira je indikov\u00E1n k l\u00E9\u010Db\u011B gesta\u010Dn\u00EDho choriokarcinomu, destruuj\u00EDc\u00EDho chorioadenomu a mola hydatidosa. \nD\u00E1le je p\u0159\u00EDpravek Methotrexate Hospira u\u017E\u00EDv\u00E1n jako\u00A0monoterapie anebo v\u00A0kombinaci s\u00A0dal\u0161\u00EDmi cytostatiky k\u00A0l\u00E9\u010Db\u011B akutn\u00ED lymfoblastick\u00E9 leuk\u00E9mie (udr\u017Eovac\u00ED terapie leuk\u00E9mie), pokro\u010Dil\u00FDch stadi\u00ED non-hodgkinsk\u00FDch lymfom\u016F, Burkittova lymfomu, epidermoidn\u00EDch karcinom\u016F hlavy a krku a pokro\u010Dil\u00FDch st\u00E1di\u00ED mycosis fungoides. \nP\u0159\u00EDpravek Methotrexate Hospira je indikov\u00E1n tak\u00E9 pro symptomatickou l\u00E9\u010Dbu psori\u00E1zy u dosp\u011Bl\u00FDch, ale vzhledem k\u00A0z\u00E1va\u017En\u00E9mu riziku l\u00E9\u010Dby pouze v\u00A0p\u0159\u00EDpadech t\u011B\u017Ek\u00E9, \u0161patn\u011B zvl\u00E1dnuteln\u00E9 psori\u00E1zy, kter\u00E1 neodpov\u00EDd\u00E1 dostate\u010Dn\u011B na jin\u00E9 typy l\u00E9\u010Dby. Diagn\u00F3za mus\u00ED b\u00FDt potvrzena biopsi\u00ED a dermatologick\u00FDm vy\u0161et\u0159en\u00EDm. Z\u00E1rove\u0148 je d\u016Fle\u017Eit\u00E9 vylou\u010Dit koincidenci psori\u00E1zy s\u00A0jin\u00FDm onemocn\u011Bn\u00EDm ovliv\u0148uj\u00EDc\u00EDm imunitn\u00ED odpov\u011B\u010F.\nD\u00E1le se p\u0159\u00EDpravek Methotrexate Hospira se pou\u017E\u00EDv\u00E1 v\u00A0terapii z\u00E1va\u017En\u00E9 aktivn\u00ED revmatoidn\u00ED artritidy, kter\u00E1 neodpov\u00EDd\u00E1 na l\u00E9\u010Dbu antirevmatiky prvn\u00ED volby, pod\u00E1van\u00FDmi samostatn\u011B nebo v\u00A0kombinaci s\u00A0inhibitory prostaglandinsyntet\u00E1zy. \n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL NOB 30X2.5MG" , "@language" : "cs" } ] }] }